AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINV

The positive CHMP opinion for upadacitinib is based on results from two induction studies and one maintenance study1-4 Crohn's disease is a chronic, systemic...

Related Keywords

Japan , Japanese , Roopal Thakkar , Gastroenterol Hepatol , Instagram , Abbvie Ltd , Linkedin , Twitter , International Organization For The Study , European Commission , Exchange Commission , American College Of Gastroenterology , European Union , Allergan , European Medicines Agency , Facebook , Crohn Colitis Foundation Of America , Committee For Medicinal Products Human Use , Medicinal Products , Human Use , About Crohn , Janus Kinase , Important Safety Information , Product Characteristics , Allergan Aesthetics , Private Securities Litigation Reform Act , Quarterly Reports , Upadacitinib Induction Therapy , Severely Active Crohn , Disease Who Failed Prior Biologics , Randomized Phase , Upadacitinib Maintenance Therapy , American College , Inflammatory Bowel , Colitis Foundation , International Organization , Scientific Workshop , New Medicinal Products , Participants With Giant Cell Arteritis , Subjects With Takayasu Arteritis , Abbvie ,